If you are trying to figure out whether Recursion Pharmaceuticals is attractively priced or a high risk speculation, a useful starting point is understanding what the current market price might be ...

Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.85, moving -3.27% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.33%. On ...

Senior researchers are leaving Elon Musk’s xAI as Anthropic discloses new safety findings and AI insiders issue unusually ...

A recent study on the development and validation of an AI-based framework for first-trimester preeclampsia risk assessment ...

At least nine engineers, including two co-founders, have announced their exits from xAI in the past week, fueling online speculation and raising questions about stability at Musk’s AI company amid ...

Zcash attracts institutional backing from Vitalik Buterin and Winklevoss twins. ZEC down 69% from $758 peak as upgrades ...

A fake news story about me, a series of AI breakthroughs and a resignation in the tech world show that 2026 could be pivotal for AI.

Artificial intelligence is once again at the heart of discussions in the tech community—but this time, not because of its ...

Creator tokens failed because speculation fed on speculation rather than measurable performance. In an AI-driven content era, the bottleneck is quality selection, not content production.

Artificial intelligence has triggered plenty of bold predictions over the past few years. Some sounded exaggerated, but out ...

AI’s rise feels faster and deeper than past tech shifts—reshaping not just what we build, but how we build, learn, and evolve in an accelerating feedback loop.

Learn how Zero-Knowledge Proofs (ZKP) provide verifiable tool execution for Model Context Protocol (MCP) in a post-quantum world. Secure your AI infrastructure today.